English | 简体中文 | 繁體中文 | 한국어
 English Press Releases
 Pharma & Biotech BioTech
Sihuan Pharmaceutical (0460.HK) Announces 2022 Annual Results
Mar 24, 2023 19:16 HKT
EC Healthcare Collaborates with New Horizon Health to form Strategic Partnership To Jointly Launch CerviClear in Hong Kong
Mar 24, 2023 17:21 HKT
With U.S. Health Systems Under Growing Pressure to Fill Staff Vacancies, CGFNS Alliance Releases Updated Standards for Ethical Recruitment of Foreign Health Workers
Mar 21, 2023 19:00 HKT
Singapore family cord blood bank Cryoviva upgrades to AXP II System for cord blood processing
Mar 21, 2023 08:30 HKT
Avantor Named Best Bioprocessing Company in Chromatography at the Asia-Pacific Bioprocessing Excellence Awards
Mar 16, 2023 09:00 HKT
Prenetics Announces Fourth Quarter and Full Year 2022 Financial Results, New Business Strategy Focused on Precision Oncology
Mar 14, 2023 22:05 HKT
Ocumension Therapeutics Announces Inclusion of Its Shares in the Shanghai-Hong Kong and Shenzhen-Hong Kong Stock Connect Programs
Mar 13, 2023 18:30 HKT
Essex Bio-Technology Announces 2022 Annual Financial Results
Mar 08, 2023 20:28 HKT
OrbusNeich Announces First Annual Results After Listing, Record Revenue of US$136.8 Million, Adjusted Net Profit Up 25% to US$26.7 Million
Mar 08, 2023 18:00 HKT
With U.S. Health Systems Under Growing Pressure to Fill Staff Vacancies, CGFNS Alliance Releases Updated Standards for Ethical Recruitment of Foreign Health Workers
Mar 07, 2023 13:30 HKT
EC Healthcare Opened the First Organic Flagship Veterinary Hospital in Hong Kong
Mar 06, 2023 15:50 HKT
Prenetics Announces Formation of Scientific Advisory Board to Support New Business Strategy in Precision Oncology
Mar 04, 2023 15:40 HKT
CATALIST-listed AOXIN Q&M reports lower revenue of RMB 140m for full year ended 31 December 2022
Mar 03, 2023 08:00 HKT
Q&M reports lower full year profits due to impairments and decrease in Covid-19 related revenue
Mar 01, 2023 23:00 HKT
Kingworld Medicines Earns "Shenzhen Time-honored Brand" Title Again
Feb 28, 2023 15:03 HKT
Malaysian Genomics Pivots to Biopharmaceuticals for Growth
Feb 24, 2023 17:30 HKT
Lepu Biopharma and Keymed Jointly Announces Global Exclusive Licence Agreement with AstraZeneca for CMG901
Feb 23, 2023 10:18 HKT
Essex and Henlius signed amendment agreement for Global Co-Development and Exclusive License Agreement for treatment of age-related macular degeneration
Feb 22, 2023 18:48 HKT
Malaysian Genomics to Offer World's First DNA-Driven Fertility Test
Feb 22, 2023 14:30 HKT
Led by Legend Capital, Macrolux Completes Nearly CNY100 million Series A Round
Feb 16, 2023 17:09 HKT
Next >>
Copyright © 2023 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: